MakeMyTrip LimitedMMYTNASDAQ

|||

Overview News Fundamentals Key Metrics TTM Financials Earnings Growth Rating Analysts Institutional Peers Historical

Alerts

Want to monitor MMYT?

Get notified when price crosses targets, volume spikes, or RSI hits oversold

Create free account to monitor MMYT

Key Statistics

About

makemytrip. com is india’s leading travel company. launched in india in 2005, makemytrip was the first travel portal in the country and is regarded as the pioneer of online travel.

CEO

Deep Kalra

makemytrip.com/ →

News

Biohaven Highlights Portfolio Progress, Positive Early Patient Data from Priority Degrader Programs and Anticipated Milestones at the 44th Annual J.P. Morgan Healthcare Conference

prnewswire.com

Discretionary Active ETFs Gain Share as Systematic Funds Lag

etftrends.com

QURE Investigation Reminder: Kessler Topaz Meltzer & Check, LLP Encourages uniQure N.V. (NASDAQ: QURE) Investors with Significant Losses to Contact the Firm

globenewswire.com

Quince Therapeutics: Good Potential In Orphan Disease In Q1 With Platform Potential

seekingalpha.com

Walmart is planning to expand a popular service. It means new delivery options from Los Angeles to Miami

fastcompany.com

I'm Willing To Be Patient With Franklin Covey

seekingalpha.com

Is the Options Market Predicting a Spike in Holley Stock?

zacks.com

Is Home Depot Stock Best Positioned If Rates Ease in 2026?

zacks.com

Meta Hires Former Trump Official As President

forbes.com

Paramount Launches Proxy Fight For Control Of Warner Bros. Discovery

forbes.com

Biogen Receives European Commission Approval for High Dose Regimen of SPINRAZA® (nusinersen) for Spinal Muscular Atrophy

globenewswire.com

EXL named a Leader in five quadrants in ISG Provider Lens™ Insurance Services Global Report

globenewswire.com

GeneDx Partners With Komodo Health to Advance Rare Disease Research

zacks.com

CRWD to Acquire SGNL: Is Identity Security the Next Growth Pillar?

zacks.com

Hims & Hers Expands Platform-Led Access to Provider-Directed Care

zacks.com

AP Upgraded to Outperform on Exits, Tariff Pass-Through & ALP

zacks.com

Thryv Holdings: Ignore Near-Term Lumps And Buy For Deep Value

seekingalpha.com

Explore More

S&P 500 Screener

Filter and sort all 500 stocks

Market Movers

Today's biggest gainers and losers

Market Heatmap

Visual sector performance

Alerts

Key Statistics

About

News

Biohaven Highlights Portfolio Progress, Positive Early Patient Data from Priority Degrader Programs and Anticipated Milestones at the 44th Annual J.P. Morgan Healthcare Conference

Discretionary Active ETFs Gain Share as Systematic Funds Lag

QURE Investigation Reminder: Kessler Topaz Meltzer & Check, LLP Encourages uniQure N.V. (NASDAQ: QURE) Investors with Significant Losses to Contact the Firm

TEVA Signs Deal With RPRX to Accelerate Development of Vitiligo Drug

Zuckerberg names banker, ex-Trump advisor as Meta president

BAE Systems rises on geopolitical uncertainty; US bank sums up the narrative

Quince Therapeutics: Good Potential In Orphan Disease In Q1 With Platform Potential

Walmart is planning to expand a popular service. It means new delivery options from Los Angeles to Miami

I'm Willing To Be Patient With Franklin Covey

Is the Options Market Predicting a Spike in Holley Stock?

Is Home Depot Stock Best Positioned If Rates Ease in 2026?

Meta Hires Former Trump Official As President

Paramount Launches Proxy Fight For Control Of Warner Bros. Discovery

Biogen Receives European Commission Approval for High Dose Regimen of SPINRAZA® (nusinersen) for Spinal Muscular Atrophy

EXL named a Leader in five quadrants in ISG Provider Lens™ Insurance Services Global Report

GeneDx Partners With Komodo Health to Advance Rare Disease Research

CRWD to Acquire SGNL: Is Identity Security the Next Growth Pillar?

Hims & Hers Expands Platform-Led Access to Provider-Directed Care

AP Upgraded to Outperform on Exits, Tariff Pass-Through & ALP

Thryv Holdings: Ignore Near-Term Lumps And Buy For Deep Value

Explore More

Biohaven Highlights Portfolio Progress, Positive Early Patient Data from Priority Degrader Programs and Anticipated Milestones at the 44th Annual J.P. Morgan Healthcare Conference

Discretionary Active ETFs Gain Share as Systematic Funds Lag

QURE Investigation Reminder: Kessler Topaz Meltzer & Check, LLP Encourages uniQure N.V. (NASDAQ: QURE) Investors with Significant Losses to Contact the Firm

TEVA Signs Deal With RPRX to Accelerate Development of Vitiligo Drug

Zuckerberg names banker, ex-Trump advisor as Meta president

BAE Systems rises on geopolitical uncertainty; US bank sums up the narrative

Quince Therapeutics: Good Potential In Orphan Disease In Q1 With Platform Potential

Walmart is planning to expand a popular service. It means new delivery options from Los Angeles to Miami

I'm Willing To Be Patient With Franklin Covey

Is the Options Market Predicting a Spike in Holley Stock?

Is Home Depot Stock Best Positioned If Rates Ease in 2026?

Meta Hires Former Trump Official As President

Paramount Launches Proxy Fight For Control Of Warner Bros. Discovery

Biogen Receives European Commission Approval for High Dose Regimen of SPINRAZA® (nusinersen) for Spinal Muscular Atrophy

EXL named a Leader in five quadrants in ISG Provider Lens™ Insurance Services Global Report

GeneDx Partners With Komodo Health to Advance Rare Disease Research

CRWD to Acquire SGNL: Is Identity Security the Next Growth Pillar?

Hims & Hers Expands Platform-Led Access to Provider-Directed Care

AP Upgraded to Outperform on Exits, Tariff Pass-Through & ALP

Thryv Holdings: Ignore Near-Term Lumps And Buy For Deep Value